Detalhe da pesquisa
1.
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.
EClinicalMedicine
; 40: 101099, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490415
2.
Global Absence and Targeting of Protective Immune States in Severe COVID-19.
Preprint
em Inglês
| PREPRINT-BIORXIV | ID: ppbiorxiv-359935
3.
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Preprint
em Inglês
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22282049